<DOC>
	<DOCNO>NCT01199874</DOCNO>
	<brief_summary>Rotavirus one common cause severe diarrhea , responsible 40 % diarrhea relate death child worldwide . Two vaccine Rotavirus , Rotarix速 Rotateq速 license many high middle income country 2006 , lack efficacy data low income country prevent WHO make universal recommendation use recently . This study conduct Pakistan look two objective : 1 . To compare immunogenicity Rotarix速 vaccine administer 6 10 week life 6 , 10 14 week life . 2 . To compare immunogenicity Rotarix速 vaccine infant breast fed time vaccine administration infant whose breast feed withhold one hour vaccine administration .</brief_summary>
	<brief_title>Immunogenicity Rotavirus Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>6 week 0 day 6 week 6 day age time enrollment . Healthy infant free chronic serious medical condition determine history physical exam time enrollment study . Written inform consent obtain parent guardian . Hypersensitivity vaccine component . Use investigational drug vaccine study vaccine within 30 day first dose study vaccine study . Use immunosuppressive drug . Previous intussusception abdominal surgery . Enrolment trial ( Simplified Antibiotic Therapy Neonatal Sepsis Trial , Management Omphalitis Trial ) . Birth weight less 1500 gram ; birth weight unknown , weight less 2000 gram 28 day . Immunoglobulin and/or blood product use since birth study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>18 Weeks</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Rotavirus</keyword>
	<keyword>Rotavirus vaccine</keyword>
	<keyword>Dosing schedule</keyword>
	<keyword>Immunogenicity</keyword>
	<keyword>Breast feeding</keyword>
	<keyword>Pakistan</keyword>
</DOC>